Foundation - What Tirzepatide Already Provides Tirzepatide is the strongest FDA-approved single drug for obesity, outperforming semaglutide in head-to-head trials
This peptide has been shown to accelerate the healing of wounds, tendons, and ligaments, reduce inflammation, and protect organs, including the heart and stomach
While long-term use has not shown safety concerns in available data, cycling helps prevent metabolic adaptation and may maintain the peptides effectiveness across multiple rounds
Each mL contains 0.9% benzyl alcohol, which acts as a bacteriostatic preservative, allowing for safe repeated withdrawals from the multiple-dose vial
The drug is administered orally in a mixture with water or feed in the following doses: poultry at the rate of 1-1.5 g of preparation per 1 liter of drinking water